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Abstract
Dual  atrioventricular  nodal  nonreentrant  tachycardia  (DAVNNT)  occurs  due  to  concurrent 
antegrade conduction over fast and slow atrioventricular nodal pathways and is treated by slow 
pathway modification. We describe a unique case of a patient with cardiac sarcoidosis who 
received inappropriate ICD shocks for DAVNNT. Atrial and ventricular device electrograms 
satisfied both rate and V>A criteria for ventricular tachycardia. We postulate that alterations in 
refractoriness and conduction as is seen in cardiac sarcoidosis (CS) may have contributed to 
occurrence of DAVNNT.
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Introduction
Simultaneous antegrade conduction over fast and slow AV nodal pathways was first described 
by Wu et al. in 1975 [1] and is referred to as a "double fire".[2] This phenomenon may result in 
DAVNNT.  We  describe  a  unique  case  of  a  patient  with  inappropriate  ICD  therapy  for 
DAVNNT.                                                 
Case  report                                        
A 42 year-old man with pulmonary and cardiac sarcoidosis (CS) diagnosed on the basis of 
mediastinal lymph node biopsy and late gadolinium enhancement on cardiac MRI was referred 
to  an  outside  institution  for  dual  chamber  implantable  cardioverter-defibrillator  (ICD)  for 
syncope, complete atrioventricular block, and moderate systolic dysfunction (ejection fraction 
40%).  He  was  treated  with  prednisone  for  three  months  and  atrioventricular  conduction 
subsequently improved. He then presented to a local emergency department after experiencing 
multiple ICD shocks preceded by palpitations.  Device interrogation was interpreted as salvos 
of non-sustained ventricular tachycardia (Figure 1). He was treated with metoprolol, diltiazem, 
and amiodarone before transfer to our institution.  
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Following admission he was noted to have a narrow complex tachycardia with a pattern of 
grouped beating and P waves visible in a 1:2 pattern;  device interrogation with concurrent 
atrial  and  ventricular  electrograms  confirmed  1:2  AV  conduction  (Figure  2).  Ventricular 
tachycardia  and  ventricular  fibrillation  zone  cut-offs  were  190  and  220  beats  per  minute 
respectively treated with anti-tachycardia pacing and biphasic shocks. Ventricular detection 
enhancements including electrogram morphology match, onset, and stability were programmed 
on. Device therapies were disabled and he was referred for electrophysiology study, which 
demonstrated consistent antegrade dual AV nodal conduction during sinus rhythm and with 
atrial pacing (Figure 3). Ventriculoatrial conduction was absent at a drive train of 600 msec. 
Atrial effective refractory period (AERP) was 700/210 msec. Slow pathway AV nodal ERP 
was 700/330 msec. Fast pathway AV nodal ERP was shorter than AERP. He was treated with 
slow pathway ablation  and has  experienced no further  palpitations  or ICD therapies  at  12 
months follow-up.
Figure 1. Initial electrograms recorded from ICD telemetry at presentation.  Atrial (A) and ventricular (V) near-
field electrograms demonstrate an irregular tachycardia with V>A which is interpreted as ventricular tachycardia  
(VT)  by  the  device  in  the  bottom  channel  marker.                         
Discussion
Double fire tachycardia is an uncommon and under-recognized entity with approximately 50 
cases  reported  in  the  literature.[2]  Prior  reports  have  identified  DAVNNT  as  a  cause  of 
reversible  cardiomyopathy  and  inappropriate  referral  for  pulmonary  vein  isolation  for 
presumed  atrial  fibrillation.[2]  The  authors  have  previously  described  a  patient  with 
DAVNNT  who  was  misdiagnosed  as  having  inappropriate  sinus  tachycardia.[3]  The 
differential diagnosis for a narrow complex tachycardia with a P:R ratio of 1:2 includes (1) 
atrial bigeminy with a low voltage P-wave masked by the preceding T-wave, (2) junctional 
bigeminy, and (3) atrioventricular nodal re-entrant tachycardia (AVNRT) with 2:1 retrograde 
block.[4]  During  electrophysiologic  testing,  the  differential  diagnosis  includes  junctional 
extrasytole and junction parasystole.  The former has a less predictable coupling interval with 
the preceeding QRS or His potential.  The latter is rare and diagnosed when the junctional 
cycle length is stable and slightly different than the sinus cycle length.[2]
Diagnosis of DAVNNT depends on the ability to demonstrate AV nodal properties.  Since the 
relationship  between  the  His  and  the  fast  and  slow  pathways  are  stable,  a  zone  of  dual 
ventricular  response  may  be  established  by  altering  the  atrial  cycle  length.  Quinidine 
suppresses junctional automaticity and exacerbates DAVNNT while isoproterenol and atropine 
suppress DAVNNT and exacerbate junctional rhythms.[2]  The authors have demonstrated that 
atrial  extrastimuli  which  terminate  tachycardia  without  His  capture  effectively  rule  out 
junctional  bigeminy.[3]  Ultimately,  definitive  proof  of  DAVNNT is  disappearance  of  the 
electrophysiologic manifestations of 1:2 AV conduction following slow pathway ablation.[2] 
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Figure 2.  Top panel shows ECG after arrival to the cardiac care unit, with narrow complex tachycardia and 
visible  P  wave  preceding  every  other  QRS  complex.  Bottom  panel  shows  concurrent  intracardiac  tracings 
through the  patient’s  ICD.  Arrows  between  the  atrial  and  ventricular  near-field  electrograms  indicate  a  1:2 
response.  The  channel  marker  shows  an  interpretation  of  ventricular  tachycardia  by  the  device.       
Figure 3.  Intracardiac tracings at 200 mm/sec sweep speed recorded during atrial pacing demonstrating an A-
HV-HV response.  At top are the surface leads followed by His and right ventricular electrogram tracings, and the 
stimulation  channel  at  the  bottom.                                       
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The  maintenance  of  DAVNNT  is  dependent  upon  the  presence  of  several  unique 
circumstances.  There must be significantly delayed conduction through the slow pathway; the 
effective refractory period of the conduction system distal to the AV node must be shorter than 
the difference between the conduction times of the fast and slow pathways; each sinus beat 
must be delayed sufficiently to allow conduction through the slow pathway to the His-Purkinje 
system;  and  retrograde  ventriculoatrial  conduction  should  be  poor  or  absent.[2]
The first catheter ablation for DAVNNT was performed in 1994 and is the treatment of choice 
given the curative potential of ablation and the high failure rate of medical management.[2] 
Slow pathway ablation may be challenging due to incessant tachycardia as well the similarity 
of  antegrade  beats  conducted  by  the  slow pathway  and  junctional  ectopy  with  retrograde 
block.  In these cases, isoproterenol infusion may help by inducing AV conduction exclusively 
via  the  fast  pathway.[5]                              
We present  the  first  known case  of  DAVNNT resulting  in  inappropriate  ICD therapy.  In 
contrast to prior reports, the initial misdiagnosis was based upon interpretation of atrial and 
ventricular  device  electrograms  which  satisfied  both  rate  and  V>A criteria  for  ventricular 
tachycardia.  The timing of ICD implantation for primary prevention of sudden death in CS is 
controversial,  and  there  is  no  universally  accepted  standard  of  risk  stratification  in  these 
patients.  Electrophysiologic testing has been suggested as a method of risk stratification in 
asymptomatic patients with imaging evidence of cardiac sarcoid, [6] but there are no data with 
respect to symptomatic patients or those requiring pacing support. A recent retrospective study 
also demonstrated a high rate of appropriate  and inappropriate  shocks in  CS patients  with 
ICDs. In that study, patients who received appropriate ICD therapies were more likely to be 
male,  have  a  history  of  syncope,  lower  left  ventricular  ejection  fraction,  and  need  for 
ventricular pacing.[7] The uncertainty over risk prediction coupled with the high event rate and 
lack  of  prospective  data  is  reflected  in  the  current  American  Heart  Association  and Heart 
Rhythm Society Guidelines, which confer a 2A indication for ICD implantation in patients 
with CS. [8]  It is of particular interest that the patient's initial presentation was complete heart 
block in the setting of cardiac sarcoidosis.  We postulate that in our patient, the alterations in 
refractoriness and conduction necessary for DAVNNT occurred as a consequence of partial 
AV  nodal  recovery  during  prednisone  treatment,  with  residual  nodal  AV  dissociation. 
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